← Back
Data updated: Jul 17, 2026
SAVAGE LABS
Pharma Pharmaceuticals
SAVAGE LABS is a pharmaceutical company with 20 FDA-approved products.
1976
Since
20
Drugs
-
Trials
0
New Drugs (2yr)
SAVAGE LABS's Key Drugs
SAVAGE LABS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
SAVAGE LABS's Recent FDA Approvals
New NDA/BLA approvals for SAVAGE LABS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
SAVAGE LABS's Therapeutic Areas
Disease areas where SAVAGE LABS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
SAVAGE LABS Pipeline Snapshot
Active clinical trials for SAVAGE LABS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1976-08-16
- Latest
- 1999-03-04
- Applications
- 34